Data about the long-term duration of antibodies after SARS-CoV-2 vaccination are still
scarce and are important to design vaccination strategies. In this study, 231 healthcare …

Objectives This study aimed to determine antibody responses in healthcare workers who
receive the BNT162b2 mRNA COVID-19 vaccine and identify factors that predict the …

The evaluation of the neutralizing capacity of anti-SARS-CoV-2 antibodies is important
because they represent real protective immunity. In this study we aimed to measure and …

Response to vaccines generally varies according to individual factors of the vaccinated
subjects such as demographics and immune status. While there are various reports of …

Objective This study investigated the sex‐associated difference in the impact of obesity on
antibody response to a COVID‐19 vaccine. Methods This study included 2,435 health care …

Background Patients with chronic renal insufficiency on maintenance haemodialysis face an
increased risk of COVID-19 induced mortality and impaired vaccine responses. To date, only …

It is not clear whether there is an association between adverse reactions and immune
response after vaccination. Seven hundred and thirty-five vaccinees from our University …

The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during
the COVID-19 pandemic. The aim of this systematic review was to examine the variations in …

Evidence about the long‐term persistence of the booster‐mediated immunity against
Omicron is mandatory for pandemic management and deployment of vaccination strategies …

Background SOBERANA 02 has been evaluated in phase I and IIa studies comparing
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …